@bijans It's causing huge problems for autoimmune patients like my daughter who need HCQ. It was life changing in treating her rare disorder, and while we haven't had issues with shortages yet, many patients aren't able to get the drug.
Inspiring story of a patient, a mother, and a #biotech who cared. The economics of ultra-rare orphan diseases can be challenging, but we must try for patients!
https://t.co/lcMQM4ZKWP